Evolution of Cryptococcus neoformans Strains from Patients with HIV/AIDS

HIV/AIDS 患者的新型隐球菌菌株的进化

基本信息

  • 批准号:
    10424470
  • 负责人:
  • 金额:
    $ 36.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-05 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Abstract This competitive renewal will continue to work on understanding the population genetic structures of Cryptococcus neoformans. With this massive genome sequencing data, we will expand it and add a functional and/or translational focus. Importantly, the sequence data are integrated with phenotypic data, animal models and human infection outcomes to help understand the genetic components that make it a deadly human pathogen.Cryptococcus neoformans represents a group of encapsulated basidiomycetous yeasts that continue to produce hundreds of thousands of cases of meningitis each year with mortality rates of 15 to over 50% depending on the health care systems and no new antifungal agents have been discovered for its treatment in 25 years. In this proposal, we will use whole genome sequences to direct a research platform to complete two Specific Aims that are framed in questions. Specific Aim 1 is: What are the genotypic and phenotypic differences between clinical and environmental strains. Specific Aim 2 examines the following question: Within clinical isolates that have already produced disease, why are some strains more virulent or aggressive than others? The goal of this proposal is three- fold. First, to use whole genome sequencing (WGS) and GWAS in a large number of strains linked to functional data in order to dial down into wild-type strains and find specific genes and/or networks important to C. neoformans fitness/survival in the mammalian host. Thus, we will identify potential weak spots in the fungus to be used for antifungal drug targets. Second, to genetically identify “bad actor” strains producing more aggressive disease behaviors that could be identified for the treating clinician to appreciate and thus adjust treatment regimens based on this knowledge of the strain’s pathobiology. Finally, this study will create a substantial infrastructure addition of a library of well-characterized wild-type strains for use by the entire cryptococcal community for future pathobiology work.
摘要

项目成果

期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comparison of Cryptococcus gattii/neoformans Species Complex to Related Genera (Papiliotrema and Naganishia) Reveal Variances in Virulence Associated Factors and Antifungal Susceptibility.
  • DOI:
    10.3389/fcimb.2021.642658
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    Oliveira LSS;Pinto LM;de Medeiros MAP;Toffaletti DL;Tenor JL;Barros TF;Neves RP;Neto RGL;Milan EP;Padovan ACB;Rocha WPDS;Perfect JR;Chaves GM
  • 通讯作者:
    Chaves GM
Copy number variation contributes to cryptic genetic variation in outbreak lineages of Cryptococcus gattii from the North American Pacific Northwest.
  • DOI:
    10.1186/s12864-016-3044-0
  • 发表时间:
    2016-09-02
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Steenwyk JL;Soghigian JS;Perfect JR;Gibbons JG
  • 通讯作者:
    Gibbons JG
Present and Future Therapy of Cryptococcus Infections.
加密环球感染的当前和未来疗法。
The virulence factor urease and its unexplored role in the metabolism of Cryptococcus neoformans.
毒力因子脲酶及其在新型隐球菌代谢中的未探索的作用。
  • DOI:
    10.1093/femsyr/foaa031
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Toplis,Barbra;Bosch,Caylin;Schwartz,IlanS;Kenyon,Chris;Boekhout,Teun;Perfect,JohnR;Botha,Alfred
  • 通讯作者:
    Botha,Alfred
The antifungal pipeline: a reality check.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John R. Perfect其他文献

Candida meningitis in two children with severe combinedimmunodeficiency
  • DOI:
    10.1016/s0022-3476(84)80493-x
  • 发表时间:
    1984-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Raymond A. Smego;Phillip W. Devoe;Hugh A. Sampson;John R. Perfect;Catherine M. Wilfert;Rebecca H. Buckley
  • 通讯作者:
    Rebecca H. Buckley
Donor-derived <em>Mycoplasma</em> and <em>Ureaplasma</em> infections in lung transplant recipients: A prospective study of donor and recipient respiratory tract screening and recipient outcomes
  • DOI:
    10.1016/j.ajt.2024.07.013
  • 发表时间:
    2024-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Patrick C.K. Tam;Barbara D. Alexander;Mark J. Lee;Rochelle G. Hardie;John M. Reynolds;John C. Haney;Ken B. Waites;John R. Perfect;Arthur W. Baker
  • 通讯作者:
    Arthur W. Baker
Potential Value of Cefoperazone in Bacterial Meningitis: Experimental Studies
  • DOI:
    10.2165/00003495-198100221-00013
  • 发表时间:
    1981-01-01
  • 期刊:
  • 影响因子:
    14.400
  • 作者:
    David T. Durack;John R. Perfect
  • 通讯作者:
    John R. Perfect
Related Species Aspergillus fumigatus Subject Collection Human Fungal Pathogens Pneumocystis
相关物种 烟曲霉 主题收集 人类真菌病原体 肺孢子虫
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wright;Francis Gigliotti;Andrew H. Limper;Sascha Brunke;John R. Perfect;Robert T. Wheeler;A. Lepak;Rebecca A. Drummond;S. Gaffen
  • 通讯作者:
    S. Gaffen
Description of Cryptococcosis Following SARS-CoV-2 Infection: A Disease Survey Through the Mycosis Study Group Education and Research Consortium (MSG-19)
SARS-CoV-2 感染后隐球菌病的描述:通过真菌病研究组教育和研究联盟 (MSG-19) 进行的疾病调查
  • DOI:
    10.1093/cid/ciad551
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    11.8
  • 作者:
    Jeremey Walker;Todd P. McCarty;Gerald McGwin;E. Ordaya;P. Vergidis;Luis Ostrosky;Mehriban Mammadova;A. Spec;A. Rauseo;John R. Perfect;Julia Messina;Gabriel Vilchez;Rachel McMullen;C. Jones;Peter G Pappas
  • 通讯作者:
    Peter G Pappas

John R. Perfect的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John R. Perfect', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    8931200
  • 财政年份:
    2015
  • 资助金额:
    $ 36.39万
  • 项目类别:
Transdisciplinary Program to Identify Novel Antifungal Targets and Inhibitors
确定新型抗真菌靶点和抑制剂的跨学科计划
  • 批准号:
    9272329
  • 财政年份:
    2015
  • 资助金额:
    $ 36.39万
  • 项目类别:
Evolution of Cryptococcus neoformans strains from patients with HIV/AIDS
来自艾滋病毒/艾滋病患者的新型隐球菌菌株的进化
  • 批准号:
    8511334
  • 财政年份:
    2011
  • 资助金额:
    $ 36.39万
  • 项目类别:
Evolution of Cryptococcus neoformans Strains from Patients with HIV/AIDS
HIV/AIDS 患者的新型隐球菌菌株的进化
  • 批准号:
    10199975
  • 财政年份:
    2011
  • 资助金额:
    $ 36.39万
  • 项目类别:
Evolution of Cryptococcus neoformans strains from patients with HIV/AIDS
来自艾滋病毒/艾滋病患者的新型隐球菌菌株的进化
  • 批准号:
    8701226
  • 财政年份:
    2011
  • 资助金额:
    $ 36.39万
  • 项目类别:
Evolution of Cryptococcus neoformans strains from patients with HIV/AIDS
来自艾滋病毒/艾滋病患者的新型隐球菌菌株的进化
  • 批准号:
    8889613
  • 财政年份:
    2011
  • 资助金额:
    $ 36.39万
  • 项目类别:
Evolution of Cryptococcus neoformans Strains from Patients with HIV/AIDS
HIV/AIDS 患者的新型隐球菌菌株的进化
  • 批准号:
    9981611
  • 财政年份:
    2011
  • 资助金额:
    $ 36.39万
  • 项目类别:
Evolution of Cryptococcus neoformans strains from patients with HIV/AIDS
来自艾滋病毒/艾滋病患者的新型隐球菌菌株的进化
  • 批准号:
    8313864
  • 财政年份:
    2011
  • 资助金额:
    $ 36.39万
  • 项目类别:
Pathobiology of C. neoformans in the Central Nervous System
中枢神经系统新型隐球菌的病理学
  • 批准号:
    8099990
  • 财政年份:
    2010
  • 资助金额:
    $ 36.39万
  • 项目类别:
Pathobiology of C. neoformans in the Central Nervous System
中枢神经系统新型隐球菌的病理学
  • 批准号:
    8237066
  • 财政年份:
    2008
  • 资助金额:
    $ 36.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了